NR-53911全细胞抗原,SARS相关冠状病毒2,分离USA-WA1/2020与未感染的对照VeroE6细胞,高表达血管紧张素转换酶2,伽马辐照(抗原制剂)
产品图片
货号/SKU
NR-53911
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、1
产品描述信息
NR-53911?? Whole Cell Antigen, SARS-Related Coronavirus 2, Isolate USA-WA1/2020 with Uninfected Control Vero E6 Cells with High Expression of Angiotensin-Converting Enzyme 2, Gamma-Irradiated(Antigen Preparations)|SARS-Related Coronavirus 2|Whole Cell Antigen, SARS-Related Coronavirus 2, Isolate USA-WA1/2020 with Uninfected Control Vero E6 Cells with High Expression of Angiotensin-Converting Enzyme 2, Gamma-Irradiated| -60°C or colder|RS Baric, E de Wit, CDCAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Whole Cell Antigen, SARS-Related Coronavirus 2, Isolate USA-WA1/2020 with Uninfected Control Vero E6 Cells with High Expression of Angiotensin-Converting Enzyme 2, Gamma-Irradiated, NR-53911.”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
NR-53911 consists of crude preparation of cell lysate and supernatant from uninfected Cercopithecus aethiops kidney epithelial cells with high expression of angiotensin-converting enzyme 2 (Vero E6-heACE2) and from cells infected with severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate USA-WA1/2020. These lysates were gamma-irradiated (5 × 106 RADs) on dry ice, followed by sonication.
NR-53911 consists of the two components listed in Table 1. Descriptions of each component are included below.
Table 1: SARS-CoV-2 Whole Cell Antigen Kit
SARS-CoV-2, isolate USA-WA1/2020 was isolated from an oropharyngeal swab from a patient with a respiratory illness who had recently returned from travel to the affected region of China and developed clinical disease (COVID-19) in January 2020 in Washington, USA.
NR-53911 is functional in ELISA. The recommended dilution of NR-53911 for ELISA is 1:2000.
Each kit contains one vial of each lysate, containing approximately 0.1 mL of gamma-irradiated and sonicated cell lysate and supernatant.
NR-53911 consists of crude preparation of cell lysate and supernatant from uninfected Cercopithecus aethiops kidney epithelial cells with high expression of angiotensin-converting enzyme 2 (Vero E6-heACE2) and from cells infected with severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate USA-WA1/2020. These lysates were gamma-irradiated (5 × 106 RADs) on dry ice, followed by sonication.
NR-53911 consists of the two components listed in Table 1. Descriptions of each component are included below.
Table 1: SARS-CoV-2 Whole Cell Antigen Kit
Lysate Type |
Catalog Number |
---|---|
Gamma-irradiated uninfected Vero E6-heACE2 cell lysate control | |
Gamma-irradiated SARS-CoV-2, isolate USA-WA1/2020 infected Vero E6-heACE2 cell lysate |
SARS-CoV-2, isolate USA-WA1/2020 was isolated from an oropharyngeal swab from a patient with a respiratory illness who had recently returned from travel to the affected region of China and developed clinical disease (COVID-19) in January 2020 in Washington, USA.
NR-53911 is functional in ELISA. The recommended dilution of NR-53911 for ELISA is 1:2000.
Each kit contains one vial of each lysate, containing approximately 0.1 mL of gamma-irradiated and sonicated cell lysate and supernatant.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID批准.
NR-53911由细胞裂解物的粗制剂和来自未感染的中清液的粗酸,具有高表达血管紧张素转换酶2(Vero E6-Healce2)和感染严重急性呼吸综合征的细胞的肾上皮细胞肾上皮细胞 - 冠状病毒2(SARS-COV-2),隔离USA-WA1 / 2020.这些裂解物在干冰上是γ-照射(5×106ards),然后超声处理.
NR-53911由表中列出的两个组成部分组成1.每个组件的描述包括在下面.
表1:sars-cov-2全细胞抗原套件
裂解物类型
bei资源目录号
伽玛辐照的未感染VERO E6-HACE2细胞裂解物控制
nr-53909
伽玛辐照的SARS-COV-2,隔离USA-WA1 / 2020受感染的VERO E6-HACE2细胞裂解物
NR-53910
SARS-COV-2,孤立USA-WA1 / 2020从患有最近从旅行到中国受影响地区的呼吸疾病的口咽疾病中分离出来的患者,并在2020年1月开始出现临床疾病(Covid-19)华盛顿,美国.
NR-53911在ELISA功能. ELISA的推荐稀释NR-53911是1:2000.
每种试剂盒含有一个每种裂解物的小瓶,含有约0.1mlγ辐照和超声化的细胞裂解物和上清液.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2023-07-18
2019-06-24
2024-08-16
2022-04-01
2024-08-16
2021-12-21
2024-03-25
2021-12-21
2022-03-22
2022-04-01
2021-12-21
2021-12-21
2022-04-01
2024-01-21
2021-12-21
2021-12-21